A phase I/IIa trial of VR 588 for the treatment of respiratory tract disordera

Trial Profile

A phase I/IIa trial of VR 588 for the treatment of respiratory tract disordera

Planning
Phase of Trial: Phase I/II

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs VR 588 (Primary)
  • Indications Respiratory tract disorders
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 21 Mar 2017 According to a Vectura media release, this trial is expected to begin in the 2H of 2017.
    • 02 Dec 2016 New trial record
    • 22 Nov 2016 According to a Vectura Group plc media release, this trial is expected to begin in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top